It is a pleasure to serve under your chairmanship, Mr Davies. I thank the right hon. Member for Orkney and Shetland for bringing this important issue to the House. I reassure him that we take this issue very seriously. The UK's leadership in genomics extends from human genomics to animal and plant genomics, with initiatives like Genomics England (GEL) and the NHS genomic medicine service transforming drug discovery, diagnosis, and patient access to treatments. We have set out a £175 million genetic healthcare strategy for life-saving programmes around cancer and rare diseases and refreshed our biological security strategy to address biosecurity in an interconnected world. I have put research security at the heart of international collaborations, setting up RCAT—a specialist advisory group connected to intelligence agencies—to check quickly whether partners are benign, hostile or dangerous before signing agreements. We will continue to manage risks properly and ensure that we defend not only the values of good and open science but our own economic security.